iiinova — where your digital self keeps evolving

Replies

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/02/2026

3⃣🚀Session Three has just started at #ACC2026 The focus turns to preclinical antimicrobial development, with talks exploring lysin biotherapeutics, anti-virulence approaches and new adjunct therapies to tackle drug-resistant infections. 🎥 Join us now: portalapp.bsac.eventsair.com/VirtualAtten...

211

Microbes.Info @microbesinfo.bsky.social · 04/02/2026

👍

000

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/02/2026

Dr Christopher Jonkergouw: "Combining dual-acting extracellular anti-virulence inhibitors with antibiotics is a powerful strategy to tackle resistance effectively without competing with the current antibiotics."🦠🔬 🎥 The Q&A is live right now: portalapp.bsac.eventsair.com/VirtualAtten... #ACC2026

210